1. Bioorg Med Chem Lett. 2007 May 1;17(9):2535-9. doi:
10.1016/j.bmcl.2007.02.012.  Epub 2007 Feb 8.

Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating 
hormone receptor-1 (MCH-R1) antagonists.

Zhang M(1), Tamiya J, Nguyen L, Rowbottom MW, Dyck B, Vickers TD, Grey J, 
Schwarz DA, Heise CE, Haelewyn J, Mistry MS, Goodfellow VS.

Author information:
(1)Department of Medicinal Chemistry, Pharmacology and Molecular Biology, 
Neurocrine Biosciences Inc., 12790 El Camino Real, San Diego, CA 92130, USA.

A series of thienopyrimidinone bis-aminopyrrolidine ureas were designed, 
synthesized, and evaluated for their ability to bind melanin-concentrating 
hormone receptor-1. These compounds exhibit potent binding affinity (K(i)=3 nM) 
and good in vitro metabolic stability.

DOI: 10.1016/j.bmcl.2007.02.012
PMID: 17329101 [Indexed for MEDLINE]
